Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
4,279.00
+37.00
+(0.87%)
At close: February 21 at 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
55,993,000
55,993,000
-1,772,000
117,590,000
73,067,000
Investing Cash Flow
-25,321,000
-25,321,000
-22,723,000
-28,848,000
-36,086,000
Financing Cash Flow
-22,720,000
-22,720,000
-24,522,000
-48,967,000
-55,908,000
End Cash Position
304,678,000
304,678,000
267,350,000
309,633,000
248,740,000
Capital Expenditure
-24,823,000
-24,823,000
-34,559,000
-40,467,000
-37,358,000
Issuance of Debt
49,825,000
49,825,000
--
44,874,000
34,918,000
Repayment of Debt
-10,000,000
-10,000,000
-29,000
-40,000,000
-35,000,000
Free Cash Flow
31,170,000
31,170,000
-36,331,000
77,123,000
35,709,000
3/31/2021 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4507.T Shionogi & Co., Ltd.
2,257.50
+2.71%
MRK.BE Merck KGaA
135.95
+1.15%
IPN.PA Ipsen S.A.
110.40
+1.19%
6185.HK CanSino Biologics Inc.
35.000
-1.41%
GALD.SW Galderma Group N
113.74
-0.02%
INDV.L Indivior PLC
688.50
-5.94%
ALKS Alkermes plc
35.32
-0.51%
PCRX Pacira BioSciences, Inc.
25.16
-2.25%
SUPN Supernus Pharmaceuticals, Inc.
33.05
-4.45%
RDY Dr. Reddy's Laboratories Limited
13.35
-0.67%